U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Potassium Acetate Injection
Status: Currently in Shortage
»Date first posted: 06/10/2019
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition

Expand all

Exela Pharma Sciences, LLC (Revised 04/16/2024)

Company Contact Information:
828-758-5474

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 3.93 g/20 mL (NDC 51754-2001-4) Channel was shipped wk of 4/8/24 Awaiting additional API for 20mL batches. Product available in 200mEq/100mL vials, NDC 51754-2004-4, cartons of 25 vials Demand increase for the drug

Hospira, Inc., a Pfizer Company (Revised 07/15/2024)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Potassium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3294-51) Limited Availability Limited Supply Available. Next Delivery: November 2024; Estimated Recovery: December 2024 Delay in shipping of the drug
Potassium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-8183-01) Limited Availability Next Delivery: August 2024; Estimated Recovery: September 2024 Delay in shipping of the drug
Potassium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3294-25) Unavailable Next Delivery: November 2024; Estimated Recovery: December 2024 Delay in shipping of the drug
Potassium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-8183-25) Available
Back to Top